Inactivation of the human cytomegalovirus US20 gene hampers productive viral replication in endothelial cells

Journal of Virology

Volumn 89, Issue 21, 2015, Pages 11092-11106

  Cavaletto, Noemi ^a   Luganini, Anna ^a   Gribaudo, Giorgio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; US20 PROTEIN; OLIGONUCLEOTIDE; US20 PROTEIN, HUMAN CYTOMEGALOVIRUS; VIRAL PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; DNA SYNTHESIS; E GENE; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; EPITHELIUM CELL; FIBROBLAST; GENE INACTIVATION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; L GENE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; US20 GENE; VIRUS ASSEMBLY; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS GENE; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS REPLICATION; ANALYSIS OF VARIANCE; BIOLOGY; CYTOMEGALOVIRUS; DNA SEQUENCE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENE SILENCING; GENETICS; IMMUNOBLOTTING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; VIROLOGY;

ANALYSIS OF VARIANCE; BASE SEQUENCE; COMPUTATIONAL BIOLOGY; CYTOMEGALOVIRUS; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENE SILENCING; HUMANS; IMMUNOBLOTTING; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84945217184     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01141-15     Document Type: Article

References (51)

1. Britt W. 2008. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr Top Microbiol Immunol 325:417-470.
2. Landolfo S, Gariglio M, Gribaudo G, Lembo D. 2003. The human cytomegalovirus. Pharmacol Ther 98:269-297. http://dx.doi.org/10.1016 /S0163-7258(03)00034-2.
3. Mocarski ES, Shenk T, Griffiths PD, Pass RF. 2013. Cytomegaloviruses, p 1960-2014. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
4. Goodrum F, Caviness K, Zagallo P. 2012. Human cytomegalovirus persistence. Cell Microbiol 14:644-655. http://dx.doi.org/10.1111/j.1462 -5822.2012.01774.x.
5. Murphy E, Shenk T. 2008. Human cytomegalovirus genomes. Curr Top Microbiol Immunol 325:1-20.
6. Davison AJ, Holton M, Dolan A, Dargan DJ, Gathered D, Hayward GS. 2013. Comparative genomics of primate cytomegaloviruses, p 1-22. In Reddehase MJ (ed), Cytomegaloviruses: from molecular pathogenesis to intervention, vol 1. Caister Academic Press, London, United Kingdom.
7. Stern-Ginossar N, Weisburd B, Michalski A, Le VT, Hein MY, Huang SX, Ma M, Shen B, Qian SB, Hengel H, Mann M, Ingolia NT, Weissman JS. 2012. Decoding human cytomegalovirus. Science 338:1088- 1093. http://dx.doi.org/10.1126/science.1227919.
8. Van Damme E, Van Loock M. 2014. Functional annotation of human cytomegalovirus gene products: an update. Front Microbiol 5:218. http: //dx.doi.org/10.3389/fmicb.2014.00218.
9. Dunn W, Chou C, Li H, Hai R, Patterson D, Stolc V, Zhu H, Liu F. 2003. Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A 100:14223-14228. http://dx.doi.org/10.1073/pnas .2334032100.
10. Yu D, Silva MC, Shenk T. 2003. Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc Natl Acad Sci U S A 100:12396-12401. http://dx.doi.org/10.1073/pnas.1635160100.
11. Lesniewski M, Das S, Skomorovska-Prokvolit Y, Wang FZ, Pellet PE. 2006. Primate cytomegalovirus US12 gene family: a distinct and diverse clade of seven-transmembrane proteins. Virology 354:286-298. http://dx .doi.org/10.1016/j.virol.2006.06.035.
12. Murphy E, Yu D, Grimwood J, Schmutz J, Dickson M, Jarvis MA, Hahn G, Nelson JA, Myers RM, Shenk T. 2003. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A 100:14976-14981. http://dx.doi.org/10.1073/pnas.2136652100.
13. Das S, Pellet PE. 2007. Members of the HCMV US12 family of predicted heptaspanning membrane proteins have unique intracellular distributions, including association with the cytoplasmic virion assembly complex. Virology 361:263-273. http://dx.doi.org/10.1016/j.virol .2006.11.019.
14. Bronzini M, Luganini A, Dell'Oste V, De Andrea M, Landolfo S, Gribaudo G. 2012. The US16 gene of human cytomegalovirus is required for efficient viral infection of endothelial and epithelial cells. J Virol 86: 6875-6888. http://dx.doi.org/10.1128/JVI.06310-11.
15. Gurczynski S, Das S, Pellet PE. 2014. Deletion of the human cytomegalovirus US17 gene increases the ratio of genomes per infectious unit and alters regulation of immune and endoplasmic reticulum stress response genes at early and late times after infection. J Virol 88:2168-2182. http://dx.doi.org/10.1128/JVI.02704-13.
16. Fielding CA, Aicheler R, Stanton RJ, Wang ECY, Han S, Seirafian S, Davies J, McSharry BP, Weekes MP, Antrobus PR, Prod'homme V, Blanchet FP, Sugrue D, Cuff S, Roberts D, Davison AJ, Lehner PJ, Wilkinson GWG, Tomasec P. 2014. Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation. PLoS Pathog 10:e1004058. http://dx.doi.org/10.1371/journal.ppat.1004058.
17. Hai R, Chu A, Li H, Unamoto S, Rider P, Liu F. 2006. Infection of human cytomegalovirus in cultured human gingival tissue. Virol J 3:84. http://dx.doi.org/10.1186/1743-422X-3-84.
18. Fiorentini S, Luganini A, Dell'Oste V, Lorusso B, Cervi E, Caccuri F, Bonardelli S, Landolfo S, Caruso A, Gribaudo G. 2011. Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte macrophage colony-stimulating factor. J Gen Virol 92:650-660. http://dx.doi.org/10.1099/vir.0.025395-0.
19. Smith IL, Taskintuna I, Rahhal FM, Powell HC, Ai E, Mueller AJ, Spector SA, Freeman WR. 1998. Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. Arch Ophthalmol 116:178-185.
20. Ryckman BJ, Jarvis MA, Drummond DD, Nelson JA, Johnson DC. 2006. Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J Virol 80:710-722. http://dx.doi.org/10.1128/JVI.80.2.710-722 .2006.
21. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG. 2005. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 33:e36. http://dx.doi.org/10.1093/nar/gni035.
22. Brune W, Nevels M, Shenk T. 2003. Murine cytomegalovirus m41 open reading frame encodes a Golgi-localized antiapoptotic protein. J Virol 77:11633-11643. http://dx.doi.org/10.1128/JVI.77.21.11633-11643.2003.
23. Luganini A, Caposio P, Landolfo S, Gribaudo G. 2008. Phosphorothioate- modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry. Antimicrob Agents Chemother 52:1111- 1120. http://dx.doi.org/10.1128/AAC.00987-07.
24. Das S, Pellet PE. 2011. Spatial relationships between markers for secretory and endosomal machinery in human cytomegalovirus-infected cells versus those in uninfected cells. J Virol 85:5864-5879. http://dx.doi.org /10.1128/JVI.00155-11.
25. Carrara G, Saraiva N, Gubser C, Johnson BF, Smith GL. 2012. Sixtransmembrane topology for Golgi anti-apoptotic protein (GAAP) and Bax inhibitor 1 (BI-1) provides model for the transmembrane Bax inhibitor- containing motif (TMBIM) family. J Biol Chem 287:15896-15905. http://dx.doi.org/10.1074/jbc.M111.336149.
26. O'Connor CM, Shenk T. 2012. Human cytomegalovirus pUL78 G protein- coupled receptor homologue is required for timely cell entry in epithelial cells but not fibroblasts. J Virol 86:11425-11433. http://dx.doi.org /10.1128/JVI.05900-11.
27. Caposio P, Luganini A, Hahn G, Landolfo S, Gribaudo G. 2007. Activation of the virus-induced IKK/NF-κB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells. Cell Microbiol 9:2040-2054. http://dx.doi.org/10.1111/j.1462-5822.2007.00936.x.
28. Tanaka N, Kimura H, Iida K, Saito K, Tsuge I, Yoshimi A, Matsuyama T, Morishima T. 2000. Quantitative analysis of cytomegalovirus load using a real-time PCR assay. J Med Virol 60:455-462. http://dx.doi.org/10.1002/(SICI)1096-9071(200004)60:4455::AID-JMV14
29. Gribaudo G, Riera L, Rudge TL, Caposio P, Johnson LF, Landolfo S. 2002. Human cytomegalovirus infection induces cellular thymidylate synthase gene expression in quiescent fibroblasts. J Gen Virol 83:2983-2993.
30. Das S, Skomorovska-Prokvolit Y, Wang FZ, Pellet PE. 2006. Infectiondependent nuclear localization of US17, a member of the US12 family of human cytomegalovirus-encoded seven-transmembrane proteins. J Virol 80:1191-1203. http://dx.doi.org/10.1128/JVI.80.3.1191-1203.2006.
31. Das S, Vasanji A, Pellet PE. 2007. Three-dimensional structure of the human cytomegalovirus virion assembly complex includes a reoriented secretory apparatus. J Virol 81:11861-11869. http://dx.doi.org/10.1128 /JVI.01077-07.
32. Tandon R, Mocarski ES. 2012. Viral and host control of cytomegalovirus maturation. Trends Microbiol 20:392-401. http://dx.doi.org/10.1016/j .tim.2012.04.008.
33. Hirokawa T, Boon-Chieng S, Mitaku S. 1998. SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics 14:378-379. http://dx.doi.org/10.1093/bioinformatics/14.4.378.
34. Claros MG, von Heijne G. 1994. TopPred II: an improved software for membrane protein structure predictions. Comput Appl Biosci 10:685-686.
35. Krogh A, Larsson B, von Heijne G, Sonnhammer EL. 2001. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305:567-580. http://dx.doi.org/10.1006/jmbi.2000.4315.
36. Nugent T, Jones D. 2009. Transmembrane protein topology prediction using support vector machines.BMCBioinformatics 10:159. http://dx.doi.org/10.1186/1471-2105-10-159.
37. Nakamura N, Rabouille C, Watson R, Nilsson T, Hui N, Slusarewicz P, Kreis TE, Warren G. 1995. Characterization of a cis-Golgi matrix protein, GM130. J Cell Biol 131:1715-1726. http://dx.doi.org/10.1083/jcb.131.6 .1715.
38. Bedard K, Szabo E, Michalak M, Opas M. 2005. Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57. Int Rev Cytol 245:91-121. http://dx.doi.org/10.1016/S0074-7696(05)45004-4.
39. Adler B, Sinzger C. 2013. Cytomegalovirus interstrain variance in cell type tropism, p 297-321. In Reddehase MJ (ed), Cytomegaloviruses: from molecular pathogenesis to intervention, vol 1. Caister Academic Press, London, United Kingdom.
40. Guo YW, Huang ES. 1993. Characterization of structurally tricistronic gene of human cytomegalovirus composed of U(s)18, U(s)19, and U(s)20. J Virol 67:2043-2054.
41. Towler JC, Ebrahimi B, Lane B, Davison AJ, Dargan DJ. 2012. Human cytomegalovirus transcriptome activity differs during replication in human fibroblast, epithelial and astrocyte cell lines. J Gen Virol 93:1046- 1058. http://dx.doi.org/10.1099/vir.0.038083-0.
42. Johnson DC, Spear PG. 1983. O-linked oligosaccharides are acquired by herpes simplex virus glycoproteins in the Golgi apparatus. Cell 32:987- 997. http://dx.doi.org/10.1016/0092-8674(83)90083-1.
43. Rojas-Rivera D, Hetz C. 2015. TMBIM protein family: ancestral regulators of cell death. Oncogene 34:269-280. http://dx.doi.org/10.1038/onc .2014.6.
44. Gubser C, Bergamaschi D, Hollinshead M, Lu X, van Kuppeveld FJ, Smith GL. 2007. A new inhibitor of apoptosis from vaccinia virus and eukaryotes. PLoS Pathog 3:e17. http://dx.doi.org/10.1371/journal.ppat .0030017.
45. Penkert RR, Kalejta RF. 2012. Tale of a tegument transactivator: the past, present and future of human CMV pp71. Future Virol 7:855-869. http: //dx.doi.org/10.2217/fvl.12.86.
46. Cristea IM, Moorman NJ, Terhune SS, Cuevas CD, O'Keefe ES, Rout MP, Chait BT, Shenk T. 2010. Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IF16 protein. J Virol 84:7803-7814. http://dx.doi.org/10 .1128/JVI.00139-10.
47. Brune W, Menard C, Heeseman J, Koszinowski UH. 2001. A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science 291:303-305. http://dx.doi.org/10.1126/science.291.5502 .303.
48. Umashankar M, Petrucelli A, Cicchini L, Caposio P, Kreklywich CN, Rak M, Bughio F, Goldman DC, Hamlin KL, Nelson JA, Fleming WH, Streblow DN, Goodrum F. 2011. A novel human cytomegalovirus locus modulates cell type-specific outcomes of infection. PLoS Pathog 7:e1002444. http://dx.doi.org/10.1371/journal.ppat.1002444.
49. Bughio F, Elliott DA, Goodrum F. 2013. An endothelial cell-specific requirement for the UL133-UL138 locus of human cytomegalovirus for efficient virus maturation. J Virol 87:3062-3075. http://dx.doi.org/10 .1128/JVI.02510-12.
50. Bughio F, Umashankar M, Wilson J, Goodrum F. 2015. Human cytomegalovirus UL135 and UL136 genes are required for post-entry tropism in endothelial cells. J Virol http://dx.doi.org/10.1128/JVI.00284-15.
51. Pellet PE, Roizman B. 2013. Herpesviruses, p 1802-1822. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA.